ResMed Sells MatrixCare Business for $490M to Frazier Healthcare Partners
ResMed sells MatrixCare software business to Frazier Healthcare Partners for $490 million. The deal helps ResMed focus on sleep and home health markets. MatrixCare's value was announced to be different in a few sources but was found to be consistent to be $708M in one source.
ResMed announced an agreement to sell its MatrixCare business to Frazier Healthcare Partners, a private equity firm. The transaction helps ResMed focus on its sleep and connected home health markets.
According to various reports, ResMed intends to sell the software business for $490 million. However, one source reported the deal value as $708 million.
While the financial details have some discrepancies, a definitive agreement has been made between the parties involved. This transaction could have implications for companies looking into the healthcare software space.
Related Stocks
Powered by SentiSense - Intelligent Market Analysis